Can I read Cytarabine/idarubicin: Gastro-oesophageal mucormycosis and mucositis: case report on EtoBox?

Cytarabine/idarubicin: Gastro-oesophageal mucormycosis and mucositis: case report is a Medicine article available to read on EtoBox.

What is Cytarabine/idarubicin: Gastro-oesophageal mucormycosis and mucositis: case report about?

Cytarabine/idarubicin ## Gastro-oesophageal mucormycosis and mucositis: case report A 60-year-old man developed gastro-oesophageal mucormycosis and mucositis during treatment with idarubicin and cytarabine for acute myeloid leukaemia [not all durations of treatments to reactions onsets and outcomes stated]. The man presented to the emergency room (ED) with fever, migratory polyarthralgia of large and small joints and night sweat. Following examinations, a diagnosis of FMS-like tyrosine kinase 3 (FLT3) negative acute myeloid leukaemia was made. He started receiving induction chemotherapy with idarubicin and cytarabine (7+3 days) [dosages and routes not stated]. Additionally, he received aciclovir, moxifloxacin and voriconazole for neutropenia prophylaxis. His medical history was significant for hyperlipidaemia, hypertension and coronary artery disease. He was an ex-smoker (30 pack-year). He revealed that, he rolled grape leaves with his family prior to his admission. He had history of cough due to allergy to lisinopril. After 7 days of induction, he became febrile (102.7°F) with an absolute neutrophil count (ANC) of 0. At that time, neutropenia prophylaxis was continued and moxiflox

Who reads Cytarabine/idarubicin: Gastro-oesophageal mucormycosis and mucositis: case report?

Publisher

Springer Science and Business Media LLC

Published

2021

Language

EN

Field

Medicine (Health Sciences)